<DOC>
	<DOCNO>NCT02046148</DOCNO>
	<brief_summary>Evaluate safety immunogenicity trivalent group B streptococcus vaccine healthy pregnant woman . The study also evaluate level GBS serotype-specific antibody infant , placental transfer pregnant woman infant level antibody breast milk .</brief_summary>
	<brief_title>Safety Immunogenicity Trivalent Group B Streptococcus Vaccine Healthy Pregnant Women</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy pregnant woman 1840 year age , inclusive 28 0/7 34 6/7 week gestation . 2 . Individuals intend breastfeed least 90 day postpartum . 3 . Individuals give write consent nature study explain accord local regulatory requirement . 4 . Individuals good health determine outcome medical history , physical examination clinical judgment investigator . 5 . Individuals comprehend comply study procedure available followup . 1 . Individuals history illness ongoing illness , opinion investigator , may pose additional risk subject participate study . 2 . Individuals know hypersensitivity component vaccine . 3 . Individuals receive plan receive license vaccine within 14 day study vaccine exception inactivate influenza vaccine may administer 7 day study vaccine . 4 . Individuals infection require systemic antibiotic antiviral treatment within 7 day prior Study Day 1 . 5 . Individuals determine high risk serious obstetrical complication , include : Gestational hypertension , defined American College Obstetricians Gynecologists guideline ( ACOG Practice Bulletin 2012 ) Gestational diabetes control diet exercise per American College Obstetricians Gynecologists guideline ( ACOG Practice Bulletin 2013 ) Preeclampsia eclampsia define American College Obstetricians Gynecologists guideline ( ACOG practice bulletin , 2002 ) HIV infection Obesity class II great ( prepregnancy BMI≥35.0 ) multiple pregnancy 6 . Individuals behavioral cognitive impairment psychiatric disease , opinion investigator , may interfere subject 's ability participate study . 7 . Individuals able comprehend follow require study procedure whole period study . 8 . Individuals know suspected impairment immune system include know suspected HIV infection HIVrelated disease , history active autoimmune disorder receipt immunosuppressive therapy . 9 . Long term use glucocorticoid , include oral parenteral prednisone ≥ 20 mg/day equivalent 2 consecutive week ( 2 week total ) within 30 day prior enrollment . Use inhale , intranasal , topical corticosteroid allow . 10 . Individuals participate clinical trial another investigational product pregnancy intent participate another clinical study time conduct study . 11 . Pregnant fetus know suspected congenital anomaly 12 . Individuals act study personnel immediate family member ( brother , sister , child , parent ) spouse study personnel . 13 . Individuals fever ( oral temperature ≥ 38°C/100.4 °F ) within 3 day prior intend study vaccination . 14 . Individuals history culture confirm GBS case infant ( ) previously bear .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Maternal vaccine</keyword>
	<keyword>GBS</keyword>
	<keyword>pregnant woman</keyword>
	<keyword>IgG</keyword>
	<keyword>IgA</keyword>
</DOC>